Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolapitant for Prevention of PONV
NCT00539721Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Oct 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of rolapitant in postoperative nausea and vomiting (PONV), sponsored by Merck & Co.. Started Oct 2007; status: completed.
02
Drugs
rolapitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00539721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539721.